Announcements Trials
Browse Landscape

Phase

Phase 2 110Phase 3 36Phase 1/2 9Phase 1 9Phase 4 3Phase 2/3 3Phase NA 2

Status

Unknown 6Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 2Plasma cell 1

Conditions

Waldenstrom Macroglobulinemia 1Recurrence 1Multiple Myeloma 1Lymphoma, Mantle-Cell 1

Interventions

Zoledronic Acid 28Saline Solution 26Metformin 25Dexamethasone 25Cyclophosphamide 23Cytarabine 22Bupivacaine 20Sodium Chloride 18Vincristine 17Methotrexate 17Letrozole 17Propofol 15Morphine 15Doxorubicin 15Prednisolone 14Docetaxel 14Dexmedetomidine 14Cisplatin 14Bevacizumab 14Oxycodone 13Imiquimod 13Fentanyl 13Capecitabine 13Rituximab 12Mercaptopurine 12Fluorouracil 12Granulocyte Colony-Stimulating Factor 11Everolimus 11Asparaginase 11Acetaminophen 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Completed × Thalidomide × Clear all
NCT02844309 2026-02-11

BDH-WM02

Institute of Hematology & Blood Diseases Hospital, China

Phase 4 Completed
44 enrolled
Lymphoid

Waldenstrom Macroglobulinemia

NCT02858804 2026-02-11

BDH-MCL01

Institute of Hematology & Blood Diseases Hospital, China

Phase 4 Completed
55 enrolled
Lymphoid

Lymphoma, Mantle-Cell

NCT00652041 2011-09-19

TaCyDexVMP7

PETHEMA Foundation

Phase 4 Completed
40 enrolled
Plasma cell

Multiple Myeloma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡